Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is a chronic, inflammatory disease that affects the central nervous system. MS can cause a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive impairment, problems with balance, over heating and pain. MS will cause impaired mobility and disability in more severe cases.
Multiple sclerosis affects neurons, the cells of the brain and spinal cord that carry information, create thought and perception, and allow the brain to control the body. Surrounding and protecting some of these neurons is a fatty layer known as the myelin sheath, which helps neurons carry electrical signals. MS causes gradual destruction of myelin and transection of neuron axons in patches throughout the brain and spinal cord. The name multiple sclerosis refers to the multiple scars on the myelin sheaths. This scarring causes symptoms which vary widely depending upon which signals are interrupted.
The predominant theory today is that MS results from attacks by an individual's immune system on the nervous system and it is therefore usually categorized as an autoimmune disease. There is a minority view that MS is not an autoimmune disease, but rather a metabolically dependent neurodegenerative disease.Although much is known about how MS causes damage, its exact cause remains unknown.
Multiple sclerosis may take several different forms, with new symptoms occurring either in discrete attacks or slowly accruing over time. Between attacks, symptoms may resolve completely, but permanent neurologic problems often persist; especially as the disease advances. MS currently does not have a cure, though several treatments are available which may slow the appearance of new symptoms.
MS primarily affects adults, with an age of onset typically between 20 and 40 years, and is more common in women than in men.
...More at Wikipedia
Related Links:
Multiple Sclerosis (MS)
Questions recently asked by other users
Latest Multiple Sclerosis News From Medical News Today.
- Relapsing-Remitting Multiple Sclerosis - Teva Completes Enrollment In Laquinimod Phase III Clinical Trial
- Environment Causes Increase In Multiple Sclerosis Among Women Only
- Nutra Pharma Announces Provision Of RPI-78M Under Compassionate Release To Adrenomyeloneuropathy (AMN) Patients
- Sheffield Hallam University (UK) Explores Exercise Intervention For Multiple Sclerosis Sufferers
- Multiple Sclerosis 'barometer' Reveals Wide Variation In Care Across Europe
- Nerve Cells Need Their Armor In The War Against Diseases
- Intraspinal Implant Of Mesenchymal Stem Cells May Not Heal The Demyelinated Spinal Cord
- Actelion's First-in-class Selective S1P1 Receptor Agonist To Enter Phase II Clinical Development
- MS Commissioning Pathway, UK
- Interferon Treatment For MS Reduces Lesions In About Half Of Patients
- Only Half Of Patients With Multiple Sclerosis Achieve And Maintain Response To Interferon Treatment
-
Farthar

-
Fancystuff

How does this condition aff... -
kmilne115

-
Rainmaker

-
queen_racewife

-
Vivschaff

My husband was diagnosed wi... -
cutee_n_camo

-
twwgigi@msn.com

